Clinical Trial Update: Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating clemastine fumarate as a myelin repair therapy in patients with acute demyelinating lesions, u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Demyelinating Diseases
• Multiple Sclerosis

Drugs mentioned

• Clemastine Fumarate (clemastine fumarate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Demyelinating Diseases, Demyelination; Corpus Callosum | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING